BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28479456)

  • 1. Contrast-Induced Nephropathy: A Fact or Fiction in Lower Limb Revascularization?
    Martínez-Rico C; Martí-Mestre X; Romera-Villegas A; Espinar-Garcia E; Iborra-Ortega E; Vila-Coll R
    Ann Vasc Surg; 2017 Oct; 44():277-281. PubMed ID: 28479456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Impact of Chronic Kidney Disease and Contrast Induced Acute Kidney Injury on Long-term Outcomes in Patients with Acute Lower Limb Ischaemia.
    Zlatanovic P; Koncar I; Dragas M; Ilic N; Sladojevic M; Mutavdzic P; Tomic I; Kostic D; Davidovic L
    Eur J Vasc Endovasc Surg; 2018 Jul; 56(1):78-86. PubMed ID: 29636253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-induced nephropathy after peripheral vascular intervention: Long-term renal outcome and risk factors for progressive renal dysfunction.
    Al Adas Z; Lodewyk K; Robinson D; Qureshi S; Kabbani LS; Sullivan B; Shepard AD; Weaver MR; Nypaver TJ
    J Vasc Surg; 2019 Mar; 69(3):913-920. PubMed ID: 30292616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and safe contrast volume thresholds for postcontrast acute kidney injury after peripheral vascular interventions.
    Lee SR; Zhuo H; Zhang Y; Dahl N; Dardik A; Ochoa Chaar CI
    J Vasc Surg; 2020 Aug; 72(2):603-610.e1. PubMed ID: 31843298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of acute kidney injury after revascularization on the development of chronic kidney disease and mortality in patients with chronic limb ischemia.
    Arora P; Davari-Farid S; Pourafkari L; Gupta A; Dosluoglu HH; Nader ND
    J Vasc Surg; 2015 Mar; 61(3):720-7. PubMed ID: 25499712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red cell distribution width predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
    Kurtul A; Yarlioglues M; Murat SN; Demircelik MB; Acikgoz SK; Ergun G; Duran M; Cetin M; Ornek E
    Angiology; 2015 May; 66(5):433-40. PubMed ID: 24834929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization.
    Fan Y; Wei Q; Cai J; Shi Y; Zhang Y; Yao L; Wang X; Lin S; Li Y; Lv J; Zhou B; Du R
    Heart Vessels; 2016 Nov; 31(11):1776-1782. PubMed ID: 26874946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of contrast material-induced nephropathy after neuroendovascular procedures.
    Prasad V; Gandhi D; Stokum C; Miller T; Jindal G
    Radiology; 2014 Dec; 273(3):853-8. PubMed ID: 25102293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbondioxide-Aided Angiography Decreases Contrast Volume and Preserves Kidney Function in Peripheral Vascular Interventions.
    Stegemann E; Tegtmeier C; Bimpong-Buta NY; Sansone R; Uhlenbruch M; Richter A; Stegemann B; Roden M; Westenfeld R; Kelm M; Heiss C
    Angiology; 2016 Oct; 67(9):875-81. PubMed ID: 26535013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbon dioxide is a cost-effective contrast medium to guide revascularization of TASC A and TASC B femoropopliteal occlusive disease.
    de Almeida Mendes C; de Arruda Martins A; Teivelis MP; Kuzniec S; Nishinari K; Krutman M; Halpern H; Wolosker N
    Ann Vasc Surg; 2014 Aug; 28(6):1473-8. PubMed ID: 24704050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast medium volume to creatinine clearance ratio: a predictor of contrast-induced nephropathy in the first 72 hours following percutaneous coronary intervention.
    Tan N; Liu Y; Zhou YL; He PC; Yang JQ; Luo JF; Chen JY
    Catheter Cardiovasc Interv; 2012 Jan; 79(1):70-5. PubMed ID: 21990069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial.
    Amini M; Salarifar M; Amirbaigloo A; Masoudkabir F; Esfahani F
    Trials; 2009 Jun; 10():45. PubMed ID: 19563648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-induced nephropathy after percutaneous coronary intervention in simple lesions: risk factors and incidence are affected by the definition utilized.
    Caruso M; Balasus F; Incalcaterra E; Ruggieri A; Evola S; Fattouch K; Bracale UM; Amodio E; Novo G; Andolina G; Novo S
    Intern Med; 2011; 50(9):983-9. PubMed ID: 21532220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute kidney injury following peripheral angiography and endovascular therapy: A systematic review of the literature.
    Prasad A; Ortiz-Lopez C; Khan A; Levin D; Kaye DM
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):264-73. PubMed ID: 26946253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast Induced Nephropathy and Long-term Renal Decline After Percutaneous Transluminal Angioplasty for Symptomatic Peripheral Arterial Disease.
    Sigterman TA; Krasznai AG; Snoeijs MG; Heijboer R; Schurink GW; Bouwman LH
    Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):386-93. PubMed ID: 26460289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast volume to creatinine clearance ratio for the prediction of contrast-induced nephropathy in patients undergoing coronary angiography or percutaneous intervention.
    Barbieri L; Verdoia M; Marino P; Suryapranata H; De Luca G;
    Eur J Prev Cardiol; 2016 Jun; 23(9):931-7. PubMed ID: 26525064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum creatinine ratio: a novel predictor of mortality after percutaneous coronary intervention in patients with normal and abnormal renal function.
    Kini AS; Sarkar K; Rafael OC; Jakkula M; Kaplish D; Lee P; Suleman J; Krishnan P; Kim MC; Sharma SK
    Catheter Cardiovasc Interv; 2009 Jul; 74(1):49-55. PubMed ID: 19288579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volume-to-creatinine clearance ratio in patients undergoing coronary angiography with or without percutaneous coronary intervention: implications of varying definitions of contrast-induced nephropathy.
    Capodanno D; Ministeri M; Cumbo S; Dalessandro V; Tamburino C
    Catheter Cardiovasc Interv; 2014 May; 83(6):907-12. PubMed ID: 23934631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.
    Worasuwannarak S; Pornratanarangsi S
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S29-34. PubMed ID: 20364554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media.
    McCullough PA; Bertrand ME; Brinker JA; Stacul F
    J Am Coll Cardiol; 2006 Aug; 48(4):692-9. PubMed ID: 16904536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.